Conflict Of Interest Disclosures
AMO has participated on advisory boards for AstraZeneca, Celgene Corporation, and Sanofi–Aventis. JW has participated on the drug advisory board for AstraZeneca. AC has served on advisory boards and speakers’ bureaus for Amgen, Roche, GlaxoSmithKline, and Merck. JB has served on advisory boards for Schering–Plough and Roche. MB holds stock in IDDI.
Original Citation
Curr Oncol 2011;18(Suppl 2):S20–7. Published online September 26, 2011; corrected after print November 14, 2011.
Author’s Description of Error
It has come to our attention that, over the course of putting together this article, we inadvertently forgot to include one of our colleagues, Dr. James Bentley, who had participated in initial discussions. This omission was a complete oversight on our part.
The correct author list, affiliations, and conflict of interest disclosures appear above. The error has been corrected in the HTML and PDF versions of the article.
© 2011 by the author. Multimed Inc.